MYP_111256
Unnamed
Anticancer
Immunology
▸
Immunomodulation
▸
Immunogenic
Standard
9 amino acids
C43H71N9O12
Standard
ATLVAAFTL
906.08 Da
5.57
-0.20
-0.39
-0.0227
2.07
0.07
0.68
8.89
152.22
0.1111
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
336.58
-1.91
12.0
12.0
26.0
64.0
1.0
8.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0012034
VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-B*15:07
5.061 μM
Predicted HLA-I binding
RECORD: Rec_0164172
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Immunogenic
melanoma; HLA-C*07:01
Clinical response
RECORD: Rec_0327182
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Immunogenic
melanoma; HLA-B*15:07
Clinical response
RECORD: Rec_0376902
VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-C*07:01
11.4259 μM
Predicted HLA-I binding